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Peptidylarginine deiminases (PADs) are phylogenetically conserved calcium-dependent enzymes 22 
which post-translationally convert arginine into citrulline in target proteins in an irreversible manner, 23 
leading to functional and structural changes in target proteins. Protein deimination can cause the 24 
generation of neo-epitopes, affect gene regulation and also allow for protein moonlighting and 25 
therefore facilitate multifaceted functions of the same protein. PADs are furthermore a key 26 
regulator of cellular release of extracellular vesicle (EVs), which are found in most body fluids and 27 
participate in cellular communication via transfer of cargo proteins and genetic material. In this 28 
study, post-translationally deiminated proteins and EVs were assessed in sera of two seal species, 29 
grey seal and harbour seal.  We report a poly-dispersed population of serum-EVs, which were 30 
positive for phylogenetically conserved EV-specific markers and characterised by transmission 31 
electron microscopy. A number of deiminated proteins critical for immune and metabolic functions 32 
were identified in the seal sera and varied somewhat between the two species under study, while 33 
some targets were in common. EV profiles of the seal sera further revealed that key microRNAs for 34 
inflammation, immunity and hypoxia also vary between the two species. Protein deimination and 35 
EVs profiles may be useful biomarkers for assessing health status of sea mammals, which face 36 
environmental challenges, including opportunistic infection, pollution and shifting habitat due to 37 
global warming.  38 
 39 
Key words: Peptidylarginine deiminases (PADs); protein deimination; Grey seal (Halichoerus 40 
gryptus); Harbour seal (Phoca vitulina); extracellular vesicles (EVs); immunity; metabolism; 41 
microRNA. 42 
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 Key immune and metabolic proteins were identified as deiminated in seal sera 48 
 EV serum profiles varied somewhat between seal species 49 
 EV microRNA cargo varied between seal species in relation to inflammatory makers miR155, 50 
miR21 and the hypoxia related miR210  51 
 EV profiles and deiminated proteins are novel biomarkers in seal sera 52 




Abbreviations:   55 
BSA: Bovine Serum Albumin  56 
CD63: CD63 antigen; granulophysin; lysosomal-associated membrane protein 3  57 
ECL: Enhanced Chemiluminescence   58 
EVs: Extracellular Vesicles 59 
F95: Pan-deimination/citrullination antibody   60 
FBS: Foetal Bovine Serum  61 
Flot-1: Flotillin-1  62 
KEGG: Kyoto Encyclopedia of Genes and Genomes  63 
kDa: Kilodalton  64 
LC-MS/MS:Liquid Chromatography Mass Spectrometry  65 
miR: microRNA  66 
NTA: Nanoparticle Tracking Analysis 67 
PAD: Peptidylarginine Deiminase 68 
SDS-PAGE: Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 69 
TBS: Tris Buffered Saline   70 
TEM: Transmission Electron Microscopy   71 
 72 
 73 
1. Introduction 74 
Peptidylarginine deiminases (PADs) are phylogenetically conserved calcium-dependent enzymes 75 
which post-translationally convert arginine into citrulline in target proteins in an irreversible manner, 76 
causing functional and structural changes in target proteins [1-4]. Protein structures which are most 77 
prone to deimination include beta-sheets and intrinsically disordered proteins, which are known to 78 
be heavily regulated by post-translational modifications [5]. A range of deiminated target proteins 79 
identified to date include nuclear, cytoplasmic and mitochondrial proteins [2,3;6-12]. Protein 80 
deimination can affect gene regulation and cause neo-epitope generation through which it can 81 
contribute to inflammatory, autoimmune and degenerative diseases [6,13]. Deimination-induced 82 
structural changes in proteins may though also allow for protein moonlighting, which is an 83 
evolutionary acquired phenomenon that can facilitate proteins to carry out a range of physiologically 84 
relevant functions within one polypeptide chain [14,15]. While some moonlighting proteins have 85 
been shown to exhibit multiple activities in different cellular locations, such as the extracellular 86 
matrix, nucleus, and cytoplasm, this ability can be a double-edged sword and besides physiological 87 
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functions, also contribute to a range of inflammatory diseases [16,17].   PADs have been studied 88 
extensively in recent years due to their key roles in mediating pathological processes in a range of 89 
chronic conditions including cancer, autoimmune and neurodegenerative diseases [3,6,13]. Crucial 90 
roles for PADs have also been described in CNS regeneration [18,19]. Furthermore, the roles for 91 
PADs in the regulation of extracellular vesicle (EVs) release, is becoming an increasingly 92 
acknowledged phylogenetically conserved pathway [20-24].  PADs are described throughout 93 
phylogeny from bacteria to mammals, with 5 tissue specific PAD isozymes in mammals, 3 in chicken, 94 
1 in bony fish [1,7,8,25], in cartilaginous fish [10], and PAD homologues in parasites [23], fungi [26] 95 
and bacteria [24]. One of the key-mechanism in immunity which is mediated by PADs is the 96 
generation of extracellular trap formation from neutrophils and other white blood cells 97 
(NETosis/ETosis). In mammals, NETosis is known to be mainly PAD4 driven [27] and is found to be a 98 
phylogenetically conserved mechanism, recently also described in pinnipeds [28,29]. Besides 99 
assessment of NETosis/ETosis in pinnipeds, hitherto no further studies have been carried out 100 
regarding assessment of other PAD-driven mechanisms, including deiminated protein products or 101 
EVs, in pinnipeds. 102 
EVs are membrane bound vesicles, released from cells and participate in cellular communication via 103 
transfer of cargo proteins and genetic material [6;30-33]. The main research carried out to date on 104 
EVs has been in the context of human pathologies, including via modulation of EV release using PAD-105 
specific inhibitors in chronic disease and cancer [20-22], host-parasite interactions [23] and in 106 
bacterial antibiotic resistance [24]. Furthermore, EVs are important biomarkers that can be used to 107 
assess pathological processes and cellular communication [34-35].  Studies on EVs in relation to 108 
physiological processes have hitherto received less attention, while recent interest in the 109 
comparative immunology field has highlighted roles for EVs and EV cargo, including deiminated 110 
proteins and microRNAs, in a range of species throughout phylogeny [9-12;36-40].  111 
Seals belong to pinnipeds, with the last common ancestor of humans and pinnipeds living about 65 112 
MY ago [41]. Pinnipeds are a diverse group of semi-aquatic marine mammals comprised of walruses, 113 
eared seals and true seals. The family Phocidae is commonly referred to as true seals or earless seals. 114 
Harbour seal (Phoca vitulina), also called common seal, belongs to the Phocidae and is the most 115 
widely distributed species of pinniped, found along temperate and Arctic marine coastlines of the 116 
Northern hemisphere.  Grey seal (Halichoerus grypus (Fabricius, 1791)), also known as Atlantic seal 117 
and the horsehead seal, is the only species classified in the genus Halichoerus of the Phocidae family. 118 
Grey seal has two subspecies, the Baltic grey seal (Halichoerus grypus grypus), which is an isolated 119 
population that exists in the Baltic Sea, and the Atlantic grey seal (Halichoerus grypus atlantica), 120 
6 
 
which is found in the North Atlantic including the United Kingdom, Orkney, the German Bight, the 121 
coastal waters of Canada and south to Nantucket in the United States of America [42]. 122 
While seals have endured a range of long-standing threats due to hunting and other anthropogenic 123 
causes of death, they are also exposed to accumulative effects of pollution and shift in habitat due 124 
to global warming and changes in sea temperature, which also predisposes them to associated 125 
changes in exposure to pathogens and opportunistic infection [43,44]. The identification of novel 126 
health biomarkers markers, such as deiminated protein- and EV-profiles, may allow for the 127 
development of novel tools to assess such impacts on seals’ health status. Furthermore, marine 128 
mammals are also highly valuable for comparative and evolutionary immunology studies, as they 129 
represent three separate lineages of extant placental mammals, which arose from terrestrial 130 
ancestors at different points in evolutionary history  and  recolonized the oceans [45]. They have 131 
undergone a range of physiological adaptions to diving [46,47] and adapted their immune system to 132 
aquatic ecosystems, including for host-parasite interactions [29].  133 
In the current study, sera from two seal species, grey seal (Halichoerus gryptus) and harbour seal 134 
(Phoca vitulina), were assessed for deiminated protein profiles and serum-derived EVs alongside EV-135 
associated microRNA cargo, indicative of immune status and hypoxia. We report for the first time 136 
deimination of key immune and metabolic proteins in seal sera and EV profiles of the two seal 137 
species under study.   138 
  139 
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2. Materials and Methods 140 
 141 
2.1 Sampling of seal sera 142 
Two seal species, grey seal (Halichoerus gryptus) (2 adult individuals, one male and one female) and 143 
harbour seal (Phoca vitulina) (2 adult individuals, both female), in Icelandic waters of Western 144 
Iceland (Breiðafjörður and  Faxaflói, for grey seal and harbour seal respectively), were utilised in this 145 
study. Sample collection had been conducted for use of these animals as negative healthy controls, 146 
in relation to research of the mass mortality in harbour seals in NW-Europe 1988-89 [48,49], and 147 
was in accordance with Icelandic laws and regulations on hunting of wild animals (64/1994). All seals 148 
used in this study were considered healthy adults, weighing from 80-100 kg for P. vitullina and 300-149 
350 kg for H. gryptus. Following euthanasia, heart blood was collected from the seals and serum 150 
isolated by centrifuging at 2000 g for 20 min. The sera were immediately frozen at -20 °C and kept 151 
until further use.  152 
 153 
2.2 Extracellular vesicle isolation and nanoparticle tracking (NTA) analysis 154 
EVs were isolated according to established protocols, using step-wise centrifugation and 155 
ultracentrifugation according to the recommendations of MISEV2018 (the minimal information for 156 
studies of extracellular vesicles 2018; [50]). The seal sera were initially diluted 1:4 in ultrafiltered 157 
(using a 0.22 μm filter) Dulbecco’s PBS (250 μl serum added to 750 μl DPBS) and centrifuged at 4,000 158 
g for 30 min at 4 °C for the removal of cell debris and apoptotic bodies. The supernatant was 159 
collected and centrifuged again at 100,000 g for 1 h at 4 °C. The resulting EV-enriched pellet was 160 
next washed by resuspending it in 1 ml of DPBS and then ultracentrifuged again at 100,000 g for 1 h 161 
at 4 °C. The resulting final EV pellet was thereafter resuspended in 100 µl DPBS and diluted 1/100 in 162 
DPBS for nanoparticle tracking analysis (NTA), based on Brownian motion of particles in suspension, 163 
using the NanoSight NS300 system (Malvern, U.K.). The NanoSight NS300 was used in conjunction 164 
with a syringe pump to ensure continuous flow of the sample, with approximately 40-60 particles 165 
per frame and videos were recorded for 5 x 60 sec. Replicate histograms generated from these 166 
recordings, using the NanoSight software (Malvern), were averaged. 167 
 168 
2.3 Transmission Electron Microscopy  169 
EVs were isolated from the seal sera as described above and the EV pellets were fixed with 2.5 % 170 
glutaraldehyde in 100 mM sodium cacodylate buffer (pH 7.0) for 1 h at 4 °C. The EVs were then 171 
resuspended in 100 mM sodium cacodylate buffer (pH 7.0), placed on to a grid with a glow 172 
discharged carbon support film and stained with 2 % aqueous Uranyl Acetate (Sigma-Aldrich). 173 
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Visualisation by TEM was carried out using the Morada CCD camera system (EMSIS, Germany). 174 
Image processing was performed using iTEM (EMSIS). 175 
. 176 
2.4 Western blotting 177 
Seal sera and serum-EV isolates (each EV pellet derived from 250 µl serum, reconstituted in 100 µl 178 
PBS after isolation and purification) were diluted 1:1 in 2 x Laemmli reducing sample buffer (BioRad, 179 
U.K.), boiled for 5 min at 100 °C and separated by SDS-PAGE on 4-20 % TGX gels (BioRad U.K.). 180 
Following gel electrophoresis, proteins were transferred to nitrocellulose membranes using semi-dry 181 
Western blotting. Even protein transfer was assessed by PonceauS staining (Sigma, U.K.) and 182 
membranes were blocked in 5 % bovine serum albumin (BSA, Sigma, U.K.) in tris buffered saline 183 
(TBS) containing 0.1% Tween-20 (TBS-T) for 1 h at room temperature (RT). Primary antibodies were 184 
diluted in TBS-T and incubation was performed at 4 °C overnight as follows: F95 pan-deimination 185 
antibody (MABN328, Merck, 1/1000); anti-PAD2, (ab50257, Abcam, 1/1000); CD63 (ab216130, 186 
1/1000); Flot-1 (ab41927, 1/2000). Following ON incubation, the membranes were washed in TBS-T 187 
for 3 x 10 min at RT and thereafter incubated in the corresponding secondary antibody (anti-rabbit 188 
IgG or anti-mouse IgM, BioRad, diluted 1/4000 in TBS-T) for 1 h, at RT. Membranes were thereafter 189 
washed for 6 x 10 min in TBS-T and visualisation was performed using enhanced chemiluminescence 190 
(ECL) and images captured using the UVP BioDoc-ITTM System (Thermo Fisher Scientific, U.K.).  191 
 192 
2.5 Immunoprecipitation and Protein Identification 193 
The Catch and Release® v2.0 immunoprecipitation kit (Merck, U.K.) was used together with the F95 194 
pan-deimination antibody (MABN328, Merck), which has been developed against a deca-195 
citrullinated peptide and specifically detects proteins modified by citrullination [51], to isolate total 196 
deiminated proteins from seal sera and serum-derived EVs. For F95 enrichment, 50 μl serum was 197 
used per species (pooled from 2 individuals, 25 µl serum per individual animal), according to the 198 
manufacturer’s instructions (Merck). For F95 enrichment from EVs, total protein was first extracted 199 
from EV pellets derived from 250 μl serum, of each of two individual seals per species, using 100 μl 200 
RIPA+ buffer per pellet on ice for 2 h, followed by centrifugation at 16,000 g for 30 min to collect the 201 
protein supernatants. Protein immunoprecipitation (F95-encrichment) was carried out on a rotating 202 
platform overnight at 4 °C, and the F95-bound proteins were eluted using denaturing elution buffer 203 
according to the manufacturer’s instructions (Merck). The F95 enriched eluates were thereafter 204 
either analysed by Western blotting or by liquid chromatography with tandem mass spectrometry 205 
(LC-MS/MS; Cambridge Proteomics, Cambridge, U.K.). Following LC-MS/MS, peak files were 206 
submitted to Mascot (Matrix Science), using in-house databases (Cambridge Proteomics) for the 207 
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identification of species-specific protein hits with the following species-specific databases: 208 
CCP_Halichoerus_grypus_20190603 (143 sequences; 35525 residues) and 209 
CCP_Phoca_vitulina_20190603 (188 sequences; 46370 residues), respectively. 210 
 211 
2.6 MicroRNA analysis of seal serum-EVs 212 
EV isolates from the seal sera were assessed for relative changes in the expression of three key miRs 213 
related to inflammation (miR21), stress-response (miR155) and hypoxia and metabolic activity 214 
(miR210), respectively.  RNA was extracted from EV preparations of the sera of two animals from 215 
each species (each EV pellet was prepared from 250 μl serum per sample as before), using Trizol 216 
(Sigma, U.K.). The purity and concentration of the isolated RNA were measured using the NanoDrop 217 
spectrophotometer at 260 nm and 280 nm absorbance. For cDNA production, the qScript microRNA 218 
cDNA Synthesis Kit (Quantabio, U.K.) was used according to the manufacturer's instructions. The 219 
cDNA was used to assess the expression of miR21, miR155 and miR210. U6-snRNA and has-let-7a-5p 220 
were used as reference RNAs for normalization of miR expression levels. The PerfeCTa SYBR Green 221 
SuperMix (Quantabio, U.K.) was used together with MystiCq microRNA qPCR primers for the miR21 222 
(hsa-miR-21-5p), mir155 (hsa-miR-155-5p) and miR210 (hsa-miR-210-5p). All miR primers were 223 
obtained from Sigma (U.K.). Thermocycling conditions were used as follows: denaturation at 95 °C 224 
for 2 min, followed by 40 cycles of 95 °C for 2 sec, 60 °C for 15 sec, and extension at 72 °C for 15 sec. 225 
The 2ΔΔCT method [52] was used for calculating relative miR expression levels and for 226 
normalisation. Each experiment was repeated in triplicates.  227 
 228 
2.7 Statistical analysis 229 
Histograms and graphs were prepared using the Nanosight NS300 software (Malvern, U.K.) and 230 
GraphPad Prism version 7 (GraphPad Software, San Diego, U.S.A.). Experiments were repeated in 231 
technical triplicates, using 2 animals per species; histograms represent mean of data and standard 232 
deviation (SD) or standard error of mean (SEM) are indicated by error bars. Significant differences 233 
were considered as p ≤ 0.05, following one-way ANOVA or Student’s t-test. 234 
 235 
3. Results 236 
3.1 PAD and deiminated proteins in seal sera and serum-derived EVs 237 
A PAD homologue was identified in the seal sera by Western blotting via cross reaction with human 238 
PAD2 at an expected 70-75 kDa size (Fig 1A) and a human cancer cell line (glioblastoma multiforme 239 
LN18, ATCC® CRL-2610™, USA) was used as a positive control for PAD2 (Fig 1A.1) [22]. Total 240 
deiminated proteins in seal sera were detected by Western blotting, using the F95 pan-deimination 241 
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antibody, revealing deimination-positive proteins in the size range of 25-150 kDa (Fig. 1B). 242 
Deiminated proteins were also detected in the serum-derived EVs by Western blotting, mainly in the 243 
size range of 25-100 kDa (Fig. 1C).  Deiminated protein candidates were further analysed by F95 244 
enrichment in conjunction with LC-MS/MS analysis. Six protein hits were identified as species-245 
specific with grey seal (Table 1), while 5 protein hits were identified to be species-specific for 246 
harbour seal (Table 2).  247 
Table 1. Deiminated proteins identified by F95 enrichment in total serum of grey seal (Halichoerus gryptus). 248 
Deiminated proteins were isolated by immunoprecipitation using the pan-deimination F95 antibody. The F95 249 
enriched eluate was analysed by LC-MS/MS and peak list files were submitted to mascot. Only peptide 250 
sequence hits scoring with H. gryptus are included. Peptide sequences and m/z values are listed.  251 







































490.2334 K.ATNYNPGSR.S 42 42 
K4JCP6_HALGR 
MHC class I antigen 








566.3133   K.KMNLKPIMR.M + Deamidated (NQ) 22 22 
ⱡ
Ions score is -10*Log(P), where P is the probability that the observed match is a random event. Individual ions 252 
scores > 14 indicated identity or extensive homology (p < 0.05). Protein scores were derived from ions scores 253 
as a non-probabilistic basis for ranking protein hits. Cut-off was set at Ions score 20. 254 
 255 
Table 2. Deiminated proteins identified by F95 enrichment in serum of harbour seal (Phoca vitulina). 256 
Deiminated proteins were isolated by immunoprecipitation using the pan-deimination F95 antibody. The F95 257 
enriched eluate was analysed by LC-MS/MS and peak list files were submitted to mascot. Only peptide 258 
sequence hits scoring with P. vitulina are included. Peptide sequences and m/z values are listed.  259 
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Ions score is -10*Log(P), where P is the probability that the observed match is a random event. Individual ions 260 
scores > 16 indicated identity or extensive homology (p < 0.05). Protein scores were derived from ions scores 261 
as a non-probabilistic basis for ranking protein hits. Cut-off was set at Ions score 20. 262 
 263 
Deiminated protein hits were further assessed for disordered regions using FoldIndex© 264 
(https://fold.weizmann.ac.il/fldbin/findex) [53,54]. A summary for disordered regions identified in 265 
the protein hits, as well as number of arginines present in the corresponding seal Uniprot sequences 266 
identified here, are summarised in Table 3 and Table 4 for grey seal and harbour seal, respectively.   267 
 268 
Table 3. FoldIndex analysis of deiminated proteins identified by F95 enrichment in serum of grey seal 269 
(Halichoerus gryptus). The number of disordered regions, residue length of the longest disordered region, 270 
total number of disordered residues, as well as number of arginines present in the total number of residues for 271 
the individual protein hits is shown. 272 










1 50 50 5  




2 25 30 6  




1 24 24 10  
(out of 148 
residues) 
K4JCP6_HALGR 
MHC class I antigen 
7 81 207 26  







3 115 128 18  




activating protein 1 
4 47 123 22  
(out of 368 
residues) 
 273 
Table 4. FoldIndex analysis of deiminated proteins identified by F95 enrichment in serum of grey seal (Phoca 274 
vitulina). The number of disordered regions, residue length of the longest disordered region, total number of 275 
disordered residues, as well as number of arginines present in the total number of residues for the individual 276 
protein hits is shown. 277 











None found NA NA 2  




1 50 50 5  
(out of 154 
residues) 
B7NZX7_PHOVI 
Cytoplasmic beta actin 
(fragment) 
None found NA NA 13  





None found NA NA 3  






None found NA NA 5  
(out of 184 
residues) 
 278 
3.2 Nanoparticle Tracking Analysis and Characterisation of Extracellular Vesicles in Seal Sera 279 
EVs isolated from seal sera were characterised by size exclusion using nanoparticle tracking analysis 280 
(NTA; Fig 2A and 2B), by Western blotting (WB; Fig 2A.1 and 2B.1) and by morphological analysis 281 
using transmission electron microscopy (TEM; Fig 2A.2 and 2B.2). A poly-dispersed population of EVs 282 
in the size range of 50 to 600 nm was observed for both species, with some differences. In grey seal, 283 
one main peak EV was observed at 147 nm (Fig 2A), while for harbour seal several main EV peaks 284 
were observed at 64 nm, 124 nm 170 nm, 258 nm 350 nm and 477 nm, respectively (Fig. 2B). 285 
Western blotting confirmed that the EVs isolated from both species were positive for the EV-specific 286 
markers CD63 and Flot-1 (Fig 2A.1 and 2B.1). EVs were further characterised by TEM, confirming 287 
typical EV morphology (Fig. 2A.2 and 2B.2).  288 
 289 
3.3 MicroRNA analysis of inflammatory and metabolic miRs in seal EVs 290 
The inflammatory and stress related miR21, miR155 and the metabolic and hypoxia related miR210 291 
were assessed in the EVs isolated from sera of the two seal species. Species-specific differences were 292 
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observed in the relative expression all three miRs, as shown in Fig. 3. Higher relative levels of miR21 293 
(3.77-fold) were found in EVs from P. vitulina (Fig. 3A), while relative miR155 expression was 18.60-294 
fold higher in EVs from P. vitulina (Fig. 3B) and miR210 relative levels were 1.73 fold higher in EVs of 295 
H. gryptus (Fig. 3C).  296 
 297 
4. Discussion 298 
In the current study, post-translationally deiminated serum protein profiles and EV profiles are 299 
described in pinnipeds as assessed in two seal species, the grey seal (Halichoerus gryptus) and 300 
harbour seal (Phoca vitulina), using two animals per species, respectively. The identification of post-301 
translational deimination in key proteins of innate and adaptive immunity, as well as metabolic 302 
proteins, highlight putative novel modes of action for moonlighting functions of these proteins via 303 
such post-translational modifications. A PAD homologue was identified at an expected 70 – 75 kDa 304 
size in the seal sera by Western blotting, similar to as reported for other mammalian and human 305 
PADs, via cross reaction with human PAD2, which is the phylogenetically most conserved PAD form 306 
[1,7,8]. Deiminated proteins were detected in both whole sera and in serum-derived EVs, indicating 307 
EV-mediated export of deiminated proteins. The identity of specific protein hits in serum was 308 
assessed using F95 enrichment in conjunction with LC-MS/MS analysis. Identified species-specific 309 
protein hits included some key immune and metabolic related proteins, which are further discussed 310 
below and were also analysed for putative disordered regions to assess their proneness to post-311 
translational modification, using FoldIndex© [53,54] (https://fold.weizmann.ac.il/fldbin/findex). 312 
Overall, deiminated protein hits identified in grey seal showed higher numbers of disordered regions 313 
and residues than proteins identified as deiminated in harbour seal and this furthermore correlated 314 
to a higher number of arginines in the deiminated protein hits identified in grey seal (Tables 3 and 4). 315 
 316 
Myoglobin was identified as deiminated in sera of both seal species under study, while haemoglobin 317 
was identified as deiminated in harbour seal only. Both haemoglobin and myoglobin are key 318 
molecules in molecular oxygen transport in the bloodstream and for its storage in skeletal muscle. 319 
Myoglobin is found at higher concentrations in myocytes of deep diving animals compared to 320 
terrestrial animals and the diving capacity of mammals is related to the myoglobin concentration in 321 
their myocytes [55,56]. Myoglobin of diving animals have been found to have more positive net 322 
surface charges compared to myoglobin in terrestrial animals, possibly to cause electrostatic 323 
repulsion among myoglobin molecules and to prevent their aggregation and maintain high protein 324 
concentration [56,57]. In diving cetaceans myoglobin and haemoglobin have been reported to 325 
contribute to hypoxia tolerance [58,59] and haemoglobin has recently been studied in harbour seals 326 
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for the regulation of oxygen dynamics during diving [47].  Haemoglobin has furthermore been found 327 
to be a major binding protein for methylmercury in the liver of dolphins [60]. The post-translational 328 
deimination of myoglobin and haemoglobin identified here, in the seals under study, may be of 329 
considerable interest both in relation to defences to toxins as well as their physiological adaption to 330 
deep-diving, furthermore as harbour seal has been found to have greater aerobic capacity [61]. 331 
Myoblobin showed the same levels of disordered regions in both seal species, while haemoglobin 332 
was identified as deiminated in harbour seal only, with 3 and 2 arginines as putative deimination 333 
sites for haemoblobin subunit alpha and beta respectively, while disordered regions were not 334 
identified. This deimination of haemoglobin identified here may be of some importance for hitherto 335 
unrecognized effects on haemoglobin function and therefore also in relation to recent studies 336 
assessing haemoglobin for oxygen regulation during deep diving in harbour seals [47]. Such 337 
deimination-mediated functional effects will though require further in-depth investigation. 338 
 339 
ApoB-100 is one of the lipoproteins found in pinnipeds and is conserved with other mammals [62]. 340 
ApoB-100 is synthesised by the liver and plays parts of innate immune responses [63]. ApoB-100 is 341 
also associated with insulin resistance and ER stress [64], as well as being linked to lipid metabolism 342 
disorders [65]. It was here identified as deiminated in grey seal only, and displays two disordered 343 
regions comprising 30 out of 313 residues and 6 arginines as putative deimination candidates. ApoB-344 
100 has recently also been reported as deiminated in the naked mole-rat, an animal with unusual 345 
resistance to hypoxia [12], but the functional contribution of such post-translational deimination of 346 
ApoB-100 has yet to be assessed in further studies.  347 
 348 
Lysozyme C was identified as deiminated in grey seal serum. Lysozymes are hydrolytic antimicrobial 349 
enzymes found in animals throughout phylogeny and play important roles in host defences [66]. 350 
Lysozyme c is a cornerstone of innate immunity, found in many body fluids and tissues, including 351 
respiratory, intestinal tract, in granules of neutrophils and in macrophages [67]. Lysozyme has 352 
immune-modulatory functions, including via regulation of the complement system [68] and provides 353 
protection against acute and chronic oxidant injury via suppression of ROS generation and OS 354 
response genes [69].  As post-translational deimination of lysozyme c has not been described before, 355 
it remains to be further explored how such deimination-mediated changes may contribute to 356 
moonlighting functions of the protein in immune modulation. In grey seal, one disordered region 357 
comprising 24 out of 148 residues of the protein hit was identified and 10 arginines, which could 358 
serve as putative deimination sites, were found within the 148 amino acid residues. Further 359 
investigation of the effects of deimination on functional effects of lysozyme c will be required to 360 
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assess the contribution of such post-translational changes on the multifaceted functions of lysozyme 361 
c.   362 
 363 
MHC class I antigen was here identified as deiminated in serum of grey seal. The major 364 
histocompatibility complex (MHC) is involved with both adaptive and innate immune systems, 365 
including via antigen processing and presentation, and is found in vertebrates throughout phylogeny 366 
[70]. Roles for MHC class I can also serve as an inhibitory ligand for natural killer cells and this 367 
mechanism can be exploited by viruses, which can inhibit various stages of the MHC class I antigen 368 
presentation pathway for immune evasion [71-73] as well as by some cancer cells, which can down-369 
regulate MHC I to avoid normal immune surveillance [74-75]. MHC I has been studied in harbour seal 370 
[76], with possible variation suggested in immune response genes in relation to susceptibility to 371 
phocine distemper virus [77] and with respect to morbillivirus infection in stranded cetaceans [78]. 372 
To what extent post-translational deimination may contribute to variable functions of MHC class I, 373 
remains to be further understood, as such post-translational changes have not been reported 374 
before. The interactions of MHC I and II with a range of deiminated proteins have previously been 375 
studied in relation to autoimmune disease [79-80], while deimination of MHC I itself has not been 376 
described. In grey seal, MHC I contains 26 arginines out of 333 residues, all of which can serve as 377 
putative deimination sites, and contains 207 disordered residues, with 7 disordered regions, 378 
whereof the longest one is 81 residues long. This indicates that MHC I is highly disordered in grey 379 
seal and therefore prone to post-translational modifications, possibly causing a range of structural 380 
protein changes which can facilitate MHC I protein moonlighting abilities. This will though require 381 
further investigation, including via site directed mutagenesis. 382 
 383 
Parathyroid hormone related protein (PTHrP) was here identified as being deiminated in serum of 384 
grey seal. PTHrP is a member of the parathyroid hormone family and acts as an endocrine, 385 
autocrine, paracrine and intracrine hormone [81]. It regulates bone resorption and epithelial-386 
mesenchymal interactions during the formation of mammary glands and is also involved in placental 387 
transfer of calcium and calcium transport to milk [82]. PTHrP is related to a range of metabolic 388 
disorders [81,83]. PTHrP can furthermore be secreted by cancer cells and in malignancies it can 389 
cause hypercalcemia [84-85]. As PTHrP has such multifaceted functions, the role for post-390 
translational deimination for facilitating its functional diversity may be of considerable interest for 391 
physiological as well as pathological processes. In grey seal, PTHrP was found to contain 18 arginines 392 
out of 188 residues of this protein hit, with a total of 128 disordered residues found overall in 3 393 
disordered regions, whereof the longest disordered region contained 115 residues. This indicates a 394 
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high level of disorder and therefore also the ability for protein moonlighting functions, including via 395 
post-translational deimination. This will though require further in depth study, also to assess which 396 
arginines would play the most critical function in relation to post-translational deimination and the 397 
resulting downstream structural and functional protein changes. 398 
 399 
Recombinase activating protein 1 (RAG-1) is involved in antibody and T-cell receptor V(D)J 400 
recombination and is essential for the diversification and maturation of B- and T-cells [86-88]. 401 
Modifications in RAG-1 are linked to immunodeficiency and autoimmunity [89-91]. Antibody 402 
diversity is known to be achieved through a two stage process, firstly by gene arrangement, which is 403 
catalysed by the RAG1/2 recombinase, and thereafter via targeted removal of cytosines 404 
(deamination), which allows for further diversification and maturation by hypermutation, gene 405 
conversion and class-switch recombination [92]. Deimination of RAG-1 has not been reported 406 
before, but in the light of diversification of the immune system throughout phylogeny, such post-407 
translational modifications may be of great interest for understanding multifaceted functions of 408 
RAG-1 via structural and functional changes caused by post-translational modifications. In grey seal, 409 
22 arginines are found within the 368 amino acid sequence of RAG-1, which contains 4 disordered 410 
regions, with a total of 123 disordered residues, whereof the longest disordered region is 47 411 
residues. Such a number of disordered regions, in addition to a high proportion of arginines, would 412 
in theory allow for a range of structural changes mediated by deimination, allowing for moonlighting 413 
functions. These putative changes will need further exploration and validation as deimination of 414 
RAG-1 has not been explored in any species so far.   415 
 416 
Cytoplasmic beta actin was identified as deiminated in harbour seal serum. Cytoplasmic beta actin is 417 
ubiquitous, expressed in all cells in different ratios and plays key roles in cell adhesion, migration, 418 
polarisation and cytokinesis [93]. Beta actin maturation, which is important for effective interaction 419 
with myosin, is furthermore related to N-terminus arginylation [94]. Alterations in actin are related 420 
to several pathologies, including tumours [95], where deimination of action has been identified and 421 
also linked to regulation in EV release [20]. Besides EV release, beta actin participates in cytoskeletal 422 
rearrangement which is also necessary for successful phagocytosis and therefore effective immune 423 
responses [96]. Deimination of beta actin has previously been linked to EV release in cancer cells 424 
[20]. Structural changes in cytoplasmic actin, caused by post-translational changes, such as 425 
deimination identified here, may contribute to their multifaceted functions. While no disordered 426 
regions were identified in harbour seal serum using FoldIndex analysis, 13 arginines are present in 427 
the 258 amino acid sequence and can serve as targets for PAD-mediated conversion of arginine into 428 
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citrulline, leading to a range of structural changes via such post-translational deimination. Further 429 
studies on changes in deimination, including assessing the consequences of individual deiminated 430 
sites, possibly through site directed mutagenesis, will be required to understand the contribution of 431 
deimination to the diverse functions of beta-actin. 432 
 433 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was identified as deiminated in harbour seal 434 
serum. Besides key metabolic functions in glycolysis, GAPDH is a moonlighting protein with 435 
pleiotropic non-metabolic functions including in apoptosis, transcription activation and axonal 436 
transport [97-100], as well as in iron metabolism [101]. GAPDH is associated to various pathologies 437 
[99] and has shown to be regulated via post-translational modifications [100,102,103]. GAPDH was 438 
recently identified as a deimination candidate in cancer [22], in EVs of the naked mole-rat, which 439 
also has unusual adaptions to hypoxia tolerance [12], as well as in EVs of teleost fish in a study 440 
assessing effects of water temperature changes on cod immunity and growth [39]. While GAPDH 441 
was not found to have disordered regions in harbour seal, using FoldIt analysis, 5 out of 184 residues 442 
of the protein sequence hit are arginines, which can serve as targets for post-translational 443 
deimination. These arginines, via deimination, may therefore contribute to its multifaceted 444 
physiological functions.  445 
It must be noted that, while disordered proteins are the protein structures which are most prone to 446 
deimination, intrinsic disorder is though not a requirement for proteins to undergo the post-447 
translational modification from arginine to citrulline [2]. 448 
 449 
The PPI enrichment p-value for the proteins above, identified as deiminated in the seals under study, 450 
was found to be 0.00212 by STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) 451 
analysis, based on sequence identifiers with the Phocidae family, which in STRING identifies 452 
sequences from the Weddell seal (Leptonychotes weddellii) (Fig. 4). MHC class-I which was not 453 
included in the analysis as a homologue with Phocidae was not found in STRING. Such an enrichment 454 
value indicates though that the identified network has significantly more interactions than expected. 455 
Therefore, these deiminated proteins have more interactions among themselves than what would 456 
be expected for a random set of proteins of similar size, drawn from the genome. Such enrichment 457 
indicates that the proteins are at least partially biologically connected, as a group. Pfam 458 
(https://pfam.xfam.org/) and SMART (Simple Modular Architecture Research Tool) protein domains 459 
identified in STRING are further highlighted in Fig. 4 and these belong to globin, glyceraldehyde-3 460 
phosphate dehydrogenase C-terminal and NAD binding domains, the parathyroid hormone family, 461 




MicroRNAs (miRs) are highly conserved small non-coding RNAs that control gene expression and 464 
regulate biological processes by targeting messenger RNAs (mRNAs). MiRs can inhibit post-465 
transcriptional translation of mRNA or enhance mRNA degradation [104]. Hitherto, limited studies 466 
have been carried out on miRs in seals, while some expression profiling has been carried out in 467 
dolphins with the aim to identify health related biomarkers in relation to organ injury [105]. Diving 468 
animals, such as seals and cetaceans, undergo physiological and morphological changes needed for 469 
life in an aquatic environment, which are marked by resistance to physiological stresses caused by a 470 
lack of oxygen, increased amounts of reactive oxygen species and high salt levels [106]. MiR210 has 471 
previously been identified as a major miR induced under hypoxia and has important roles in 472 
mitochondrial metabolism, DNA damage response, cell proliferation and apoptosis [104]. MiR210 473 
has a regulatory role in mitochondrial metabolism [107], as well as in cell glycolytic activity, and is 474 
also linked to inflammation [108]. MiR210 has been identified as a regulator of the hypoxia pathway 475 
and to have pro-apoptotic functions under normal oxygen conditions, while anti-apoptotic effects 476 
have been observed under hypoxic conditions [109,110]. In the current study, miR210 was found to 477 
be higher expressed in grey seal than in harbour seal and this may possibly reflect physiological 478 
differences between these species in relation to mitochondrial metabolism and oxygen transport.  479 
MiR21 is strongly conserved throughout evolution, is a main immune regulatory and onco-related 480 
miR and is also associated to chronic diseases [111-113]. While many experimentally verified targets 481 
of miR21 are tumour suppressors, miR21 is also linked to cardiac disease and oxidative stress [114]. 482 
Less is known about physiological roles of miR21. In the current study miR21 was found to be higher 483 
expressed in harbour seal, compared to grey seal. Whether this difference species specific, or due to 484 
differences in immune and health status of the individual animals, remains to be further investigated 485 
as this could not be assessed in the current study due to only two individuals used per species. Roles 486 
for miR21 in immune responses of aquatic animals have previously been identified in cetaceans [38], 487 
as well as in teleost fish, where miR21 was found to regulate cytokine expression following immune 488 
stimulation [115].   489 
In mammals, miR155 is known to be a major inflammatory related miR, linked to inflammatory and 490 
stress responses [116]. In the current study miR155 was higher expressed in grey seal than in 491 
harbour seal. As no previous studies have been carried out on these two miRs in seals, it remains to 492 
be fully understood which specific functions these have in seal physiology and immunity.  493 
Both miR21 and miR155 have previously been associated to viral infections in fish [117] and found to 494 
be upregulated in fish exposed to chronic inflammation induced by [C8mim]Br [118]. Temperature 495 
dependent effects on miR155 have also been observed in teleost fish [39]. The interspecies 496 
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differences in miR expression observed here in the two seal species under study may indicate that 497 
levels of these miRs vary between species, depending on their habitat and metabolic activity. This 498 
may though also reflect different health status of the individual animals used. As only two animals 499 
per species were assessed in the current study, such species specific differences need to be further 500 
evaluated. Effects of health status have indeed previously been observed on phocid immune 501 
function and seals dive duration has furthermore been shown to affect immune cell response [119]. 502 
 503 
This study reports deiminated proteins in seal sera and serum-derived EVs. Given that the animals 504 
were from similar demographic locations (waters of Western-Iceland), all adults and considered in 505 
good health, the findings presented in the current study should reflect baseline physiological 506 
parameters of these species. Due to the fact that the seal proteomes are not fully annotated, the 507 
hits identified here must underestimate the amount of deiminated proteins present in seal sera. 508 
Post-translational deimination of some specific key immune and metabolic factors in seals was 509 
though identified, therefore bringing a novel aspect of protein moonlighting functions of these 510 
proteins via such post-translational deimination. Research on EVs is a relatively new field in 511 
comparative immunology and to our knowledge this is the first description of EVs in pinnipeds. 512 
Recent comparative studies on EVs have focussed on some aquatic animal species, including teleost 513 
and cartilaginous fish [9,10,36,37,39;120- 125]. As PADs have been identified to be phylogenetically 514 
conserved regulators of EV release, including in pathologies and host-pathogen interactions [20-24], 515 
their contribution in EV-mediated communication in response to physiological and 516 
pathophysiological processes throughout phylogeny remains an emerging field of study, warranted 517 
further exploration.  518 
In continuation of the current study, which provides the first baseline for these parameters in 519 
pinnipeds, the assessment of changes in deiminated proteins and EV profiles in seals, may be of 520 
interest for monitoring immunological responses to environmental changes, including infection, 521 
toxicology and shifts in habitat. This will require further development and refinement of these newly 522 
identified parameters presented in the current study. Furthermore, findings in deep-diving 523 
mammals, with adaptions to hypoxia, may be of considerable translatable value for informing 524 
studies on hypoxia-related human pathologies, cancer and neurodegenerative diseases. 525 
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  1006 
Figure legends 1007 
Fig. 1. PAD and deiminated proteins in seal sera and EVs. A. A seal PAD homologue was identified at 1008 
the expected size of approximately 70-75 kDa for both seal species (H.gryptus, P.vitulina), using an 1009 
anti-human PAD2 specific antibody. Figure A.1 shows a human control sample (protein isolate from 1010 
human glioblastoma cell line LN18), showing human PAD2 at a similar size, just below 75 kDa. The 1011 
protein size standard (std) is indicated at the left of both blots. B. Total deiminated proteins were 1012 
identified in seal sera, using the F95 pan-deimination specific antibody. C. Total deiminated proteins 1013 
were identified in EVs isolated from the seal sera, using the F95 pan-deimination specific antibody. 1014 
 1015 
Fig. 2. Extracellular vesicle profiling in seal sera. A. Nanoparticle tracking analysis shows a size 1016 
distribution of EVs from grey seal (Halichoerus grypus) in the range of 30 to 600 nm, with one main 1017 
peak at 147 nm. The black line represents the mean and the red lines represent the standard error of 1018 
the mean (SEM), based on five 60 sec replicate video recordings of the same sample. A.1 Western 1019 
blotting analysis confirms that grey seal EVs are positive for the EV-specific markers CD63 and Flot-1. 1020 
A.2. Transmission electron microscopy (TEM) analysis of grey seal serum-derived EVs shows typical 1021 
30 
 
EV morphology; scale bar is 100 nm in all figures. B. Nanoparticle tracking analysis shows a poly-1022 
dispersed population of EVs from harbour seal (Phoca vitulina) in the size range of 50 to 600 nm, 1023 
with peaks at 54, 124, 170, 258m 360 and 477 nm, respectively. B.1 Harbour seal EVs are positive for 1024 
the EV-specific markers CD63 and Flot-1, as confirmed by Western blotting. B.2. Transmission 1025 
electron microscopy (TEM) analysis of harbour seal serum-derived EVs shows typical EV morphology; 1026 
scale bar is 100 nm in all figures. 1027 
 1028 
Fig. 3. MicroRNA analysis of seal serum-derived EVs. A. The inflammatory related miR21 relative 1029 
expression varied between the two seal species and was significantly higher (3.77-fold) in EVs from 1030 
P. vitulina. B. The inflammatory related miR155 varied significantly between the two seal species and 1031 
was 18.60-fold higher in EVs from P. vitulina. C. The hypoxia related miR210 showed significant 1032 
differences between seal species and was 1.73 fold higher in EVs of H. gryptus.  Analysis for each 1033 
microRNA was carried out using 2 animals per species (n=2) and performed in technical triplicates. 1034 
The error bar represents the standard deviation (SD); exact p-values are indicated. 1035 
 1036 
Fig. 4.  Protein-protein interaction networks of the deiminated proteins identified in sera of both 1037 
seal species under study (P. vitulina and H. gryptus), based on sequence identifiers with the Phocidae 1038 
family, which in STRING identifies sequences from the Weddell seal (Leptonychotes weddellii). 1039 
Coloured nodes represent query proteins and first shell of interactors; white nodes are second shell 1040 
of interactors. Coloured lines indicate whether protein interactions are identified via known 1041 
interactions (curated databases, experimentally determined), predicted interactions (gene 1042 
neighbourhood, gene fusion, gene co-occurrence) or via text mining, co-expression or protein 1043 
homology (see the colour key for connective lines included in the figure). Identified PFAM protein 1044 
domains are highlighted as follows: red=globin; dark blue=glyceraldehyde 3-phosphatase 1045 
dehydrogenase C-terminal domain; light green=glyceraldehyde 3-phosphatase dehydrogenase NAD 1046 
binding domain; yellow=parathyroid hormone family; pink=phosphoglycerate kinase; dark 1047 
green=fructose-bisphosphate aldolase class-I. The following SMART protein domains are highlighted 1048 
as follows: light blue=glyceraldehyde 3-phosphatase dehydrogenase NAD binding domain; 1049 
orange=parathyroid hormone. 1050 
 1051 
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